J Korean Med Sci.  2005 Jun;20(3):468-472. 10.3346/jkms.2005.20.3.468.

Selected Adnexal Cystic Masses in Postmenopausal Women Can be Safely Managed by Laparoscopy

• Lee JW
• Kim CJ
• Lee JE
• Lee SJ
• Kim BG
• Lee JH
• Bae DS
• Park CS

• KMID: 1778508
• DOI: http://doi.org/10.3346/jkms.2005.20.3.468

Abstract

The aim of this study was to assess the efficacy and safety of laparoscopic treatment for adnexal cystic masses that were predicted to be benign in postmenopausal women. Postmenopausal women found to have an adnexal cystic mass were retrospectively evaluated with transvaginal ultrasonography, and serum CA-125 levels. The selection criteria were adnexal cystic masses greater than 3 cm but less than 10 cm, the masses were in the benign range (4-8) of Sassone's scoring system for transvaginal ultrasonography, and the patients had serum CA-125 levels less than 65 IU/mL. Two hundred nineteen women fulfilled the criteria and underwent operative laparoscopy. Almost all the masses (99.5%) were accurately predicted to be benign except for one borderline ovarian tumor. Two hundreds thirteen (97.3%) women were successfully managed by operative laparoscopy and six (2.7%) required laparotomy. For the patients managed by laparoscopy, the mean operative time was 51.3 min; the mean hospital stay was 2.5 days. There was no significant morbidity and surgery-related mortality. The combination of the Sassone's scoring system for transvaginal ultrasonography and serum CA-125 level can accurately predict benign cystic masses, and operative laparoscopy is technically feasible and safe for the management of adnexal mass in postmenopausal women.

Keyword

Postmenopause; Adnexa Uteri; Laparoscopy; Ultrasonography; CA-125 Antigen

MeSH Terms

Adnexal Diseases/blood/*surgery/ultrasonography
Aged
CA-125 Antigen/blood
Cysts/blood/*surgery/ultrasonography
Female
Humans
Laparoscopy/*methods
Middle Aged
*Postmenopause
Retrospective Studies
Treatment Outcome
Ultrasonography/methods

Reference

1. DiSaia PJ, Creasman William T.. The adnexal mass and early ovarian cancer, Clinical gynecologic oncology. 2002. 6th ed. St. Louis C.V.: Mosby;259–288.

2. Granberg S, Wikland M, Jansson I. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol. 1989. 35:139–144.

3. Rulin MC, Preston AL. Adnexal masses in postmenopausal women. Obstet Gynecol. 1987. 70:578–581.

4. Parker WH, Berek JS. Management of selected cystic adnexal masses in postmenopausal women by operative laparoscopy: a pilot study. Am J Obstet Gynecol. 1990. 163:1574–1577.

5. Shalev E, Peleg D. Laparoscopic treatment of adnexal torsion. Surg Gynecol Obstet. 1993. 176:448–450.

6. Higgins RV, van Nagell JR Jr, Donaldson ES, Gallion HH, Pavlik EJ, Endicott B, Woods CH. Transvaginal sonography as a screening method for ovarian cancer. Gynecol Oncol. 1989. 34:402–406.

7. Goldstein SR, Subramanyam B, Snyder JR, Beller U, Raghavendra BN, Beckman EM. The postmenopausal cystic adnexal mass: the potential role of ultrasound in conservative management. Obstet Gynecol. 1989. 73:8–10.

8. Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol. 1991. 78:70–76.

9. Varras M. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer. Clin Exp Obstet Gynecol. 2004. 31:85–98.

10. Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR Jr, Knapp RC. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983. 309:883–887.

11. Chen DX, Schwartz PE, Li XG, Yang Z. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet Gynecol. 1988. 72:23–27.

12. Maggino T, Gadducci A, D'Addario V, Pecorelli S, Lissoni A, Stella M, Romagnolo C, Federghini M, Zucca S, Trio D, Trovò S. Prospective multicenter study on CA 125 in postmenopausal pelvic masses. Gynecol Oncol. 1994. 54:117–123.

13. Komai K, Nishida T. [Tumor marker in ovarian cancer]. Gan To Kagaku Ryoho. 2002. 29:481–486.

14. Milojkovic M, Hrgovic Z, Hrgovic I, Jonat W, Maass N, Bukovic D. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis. Arch Gynecol Obstet. 2004. 269:176–180.

15. Sadik S, Onoglu AS, Gokdeniz R, Turan E, Taskin O, Wheeler JM. Laparoscopic management of selected adnexal masses. J Am Assoc Gynecol Laparosc. 1999. 6:313–316.

16. Mendilcioglu I, Zorlu CG, Trak B, Ciftci C, Akinci Z. Laparoscopic management of adnexal masses. Safety and effectiveness. J Reprod Med. 2002. 47:36–40.

17. Yuen PM, Yu KM, Yip SK, Lau WC, Rogers MS, Chang A. A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol. 1997. 177:109–114.

18. Mais V, Guerriero S, Ajossa S, Angiolucci M, Paoletti AM, Melis GB. The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertil Steril. 1993. 60:776–780.

19. Stein SM, Laifer-Narin S, Johnson MB, Roman LD, Muderspach LI, Tyszka JM, Ralls PW. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. AJR Am J Roentgenol. 1995. 164:381–386.

20. Valentin L, Sladkevicius P, Marsal K. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol. 1994. 83:425–433.

21. Alcazar JL, Ruiz-Perez ML, Errasti T. Transvaginal color Doppler sonography in adnexal masses: which parameter performs best? Ultrasound Obstet Gynecol. 1996. 8:114–119.

22. Buy JN, Ghossain MA, Hugol D, Hassen K, Sciot C, Truc JB, Poitout P, Vadrot D. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. AJR Am J Roentgenol. 1996. 166:385–393.

23. Sengoku K, Satoh T, Saitoh S, Abe M, Ishikawa M. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy. Int J Gynaecol Obstet. 1994. 46:39–43.

24. Anandakumar C, Chew S, Wong YC, Chia D, Ratnam SS. Role of transvaginal ultrasound color flow imaging and Doppler waveform analysis in differentiating between benign and malignant ovarian tumors. Ultrasound Obstet Gynecol. 1996. 7:280–284.

25. Kurjak A, Predanic M. New scoring system for prediction of ovarian malignancy based on transvaginal color Doppler sonography. J Ultrasound Med. 1992. 11:631–638.

26. Zanetta G, Vergani P, Lissoni A. Color Doppler ultrasound in the preoperative assessment of adnexal masses. Acta Obstet Gynecol Scand. 1994. 73:637–641.

27. Krissi H, Dekel A, Hava IB, Orvieto R, Dicker D, Shalev J, Ben-Rafael Z. Laparoscopic management of suspicious ovarian cysts in elderly, postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 1999. 83:53–56.

28. Shalev E, Eliyahu S, Peleg D, Tsabari A. Laparoscopic management of adnexal cystic masses in postmenopausal women. Obstet Gynecol. 1994. 83:594–596.

29. Parker WH, Levine RL, Howard FM, Sansone B, Berek JS. A multicenter study of laparoscopic management of selected cystic adnexal masses in postmenopausal women. J Am Coll Surg. 1994. 179:733–737.

30. Twaalfhoven FC, Peters AA, Trimbos JB, Hermans J, Fleuren GJ. The accuracy of frozen section diagnosis of ovarian tumors. Gynecol Oncol. 1991. 41:189–192.